Digital Pathology Market to Grow at a CAGR of 7.8% from 2025 to 2032 | SkyQuest Technology Consulting

The digital pathology market is anticipated to increase due to the global increase in chronic conditions like cancer, cardiovascular disorders, and diabetes fuels demand for advanced diagnostic solutions. Digital pathology supports quicker, more accurate diagnosis and treatment planning, enhancing patient outcomes.

WESTFORD, Mass., Sept. 1, 2025 /PRNewswire/ -- SkyQuest Technology Consulting published a report, titled, Digital Pathology Market - Global Opportunity Analysis and Industry Forecast, 2025-2032", valued at USD 1.05 Billion in 2024. With a projected CAGR of 7.8% from 2025 to 2032, the market is expected to reach USD 1.91 Billion by the end of 2032. Innovations in whole slide imaging technology are driving digital pathology growth by enabling high-resolution image capture, remote consultations, and AI-assisted analysis. These advancements improve workflow accuracy and efficiency, making digital systems more appealing to medical institutions transitioning from traditional glass-slide methods to modern, digitized platforms for faster pathology services.

Get Free Sample Report Copy: https://www.skyquestt.com/sample-request/digital-pathology-market 

Digital Pathology Market Key Growth Drivers

The digital pathology market has experienced significant growth owing to expanding healthcare access needs, especially in rural and underserved areas, telepathology is gaining momentum. Digital pathology allows remote sharing of slides for expert consultation, reducing diagnosis turnaround time. This accessibility is particularly valuable in global regions lacking specialized pathologists, making remote diagnostics a key growth factor in the market.

Another key factor driving the market growth is the incorporation of AI and machine learning into digital pathology enhances image analysis, pattern recognition, and diagnostic precision. AI tools can identify anomalies and assist pathologists in detecting early-stage diseases. This technological synergy boosts diagnostic confidence and operational speed, prompting more healthcare providers to adopt digital pathology solutions.

Recent Developments in Digital Pathology Market

• In April 2025, ATA Action announced its acquisition of the Digital Therapeutics Alliance (DTA), forming a new entity called the Advancing Digital Health Coalition. This strategic merger brings together policy and advocacy efforts under one roof, aiming to accelerate the adoption of innovative digital health technologies and enhance patient care delivery across the healthcare system.
• In April 2025, Click Therapeutics received FDA marketing authorization for its prescription digital therapeutic, CT-132, designed for the preventive treatment of episodic migraine in adults. This marks a significant regulatory milestone, with the FDA granting De Novo Classification, making CT-132 the first approved prescription digital therapeutic in this specific indication.
• In March 2025, Dassault Systèmes made a strategic investment in Click Therapeutics to deepen its involvement in the digital therapeutics space. The move supports Dassault's broader goal of transforming the patient experience by integrating end-to-end digital solutions across the life sciences and healthcare ecosystem.

Speak to our Analyst: https://www.skyquestt.com/speak-with-analyst/digital-pathology-market 

Major Challenges in Digital Pathology Industry

The absence of universal standards for image formats, software interoperability, and diagnostic protocols creates integration challenges. Different vendors use proprietary systems, limiting seamless data sharing and workflow continuity. This lack of standardization hinders collaboration between institutions, and slows the global adoption of digital pathology solutions in clinical and research settings.

Implementing and maintaining digital pathology systems requires specialized IT support, digital imaging knowledge, and trained personnel. Many healthcare facilities lack adequately skilled professionals, especially in low-resource settings. This expertise gap leads to underutilization of installed systems, and reluctance among, institutions to transition from traditional to digital pathology practices.

Competitive Landscape

The competitive landscape of the global digital pathology market is shaped by key players like Roche, Leica Biosystems, Philips, Hamamatsu Photonics, and Proscia. Companies focus on strategies such as AI integration, product innovation, and partnerships. For instance, Philips emphasizes AI-powered diagnostics, while Proscia expands its Concentriq platform. Roche leverages FDA-cleared scanners for market leadership, and Leica collaborates with Indica Labs to enhance AI-enabled digital workflows and diagnostic efficiency.

The major players in the digital pathology industry include,

• Koninklijke Philips N.V.
• Leica Biosystems (Danaher Corporation)
• Roche Diagnostics (F. Hoffmann-La Roche)
• Hologic, Inc.
• Hamamatsu Photonics
• 3DHISTECH
• GE Healthcare
• Akoya Biosciences, Inc.
• Fujifilm Holdings Corporation
• Apollo Enterprise Imaging
• Olympus Corporation
• Mikroscan Technologies
• Inspirata
• PerkinElmer
• Huron Digital Pathology
• Sectra AB
• PathAI
• Indica Labs
• Nikon Corporation
• Visiopharm

Digital Pathology Market Segmental Analysis

Global Digital Pathology Market is segmented by Product, Type, Application, End-use and region.

• Based on Product, the market is segmented into Scanners, Software, Deployment Model and Storage System.
• Based on Type, the market is segmented into Human Pathology and Veterinary Pathology.
• Based on Application, the market is segmented into Drug Discovery & Development, Academic Research and Disease Diagnosis.
• Based on End-use, the market is segmented into Hospitals, Biotech & Pharma Companies, Diagnostic Labs and Academic & Research Institutes.
• Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Regional Outlook

North America dominates the global digital pathology market due to advanced healthcare infrastructure, high adoption of AI in diagnostics, and significant investment in digital health technologies. The U.S. leads the region, driven by growing cancer prevalence, regulatory support, and presence of major market players like Roche and Philips. Additionally, increasing demand for remote diagnostics and telepathology in academic and clinical settings accelerates market growth, making North America a hub for innovation and implementation in digital pathology.

Asia Pacific is witnessing rapid growth in the digital pathology market due to expanding healthcare infrastructure, rising cancer incidence, and increasing investments in AI-driven diagnostics. Countries like China, Japan, and India are actively adopting digital solutions to address pathologist shortages and enhance diagnostic accuracy. Government initiatives promoting healthcare digitization and collaborations with global tech firms further fuel adoption. The region's cost-effective clinical trials and academic research institutions also contribute to making Asia Pacific a dynamic, fast-growing digital pathology market.

Europe holds a significant share in the global digital pathology market, driven by strong healthcare systems, government support for digital health initiatives, and widespread use of telepathology. Countries like Germany, the UK, and the Netherlands lead adoption, supported by research funding and academic collaborations. The region emphasizes AI integration and interoperability standards, enhancing diagnostic accuracy and workflow efficiency. Rising cancer cases and a push for cross-border medical collaboration, further accelerate digital pathology adoption across European healthcare institutions and research centers.

The Middle East and Africa digital pathology market is growing steadily due to increasing cancer prevalence and rising healthcare investments. Countries like Saudi Arabia, UAE, and South Africa are adopting digital pathology to improve diagnostic accuracy and enable telepathology services in remote areas. Government initiatives supporting healthcare digitization and growing awareness of advanced diagnostics are key drivers. Despite infrastructure challenges, the region shows promising growth potential with increasing adoption of AI and cloud-based pathology solutions.

Latin America's digital pathology market is growing steadily, driven by rising cancer rates and increasing demand for telepathology in underserved regions. Brazil and Mexico lead adoption, supported by healthcare infrastructure improvements and government initiatives promoting digital diagnostics. Devices dominate the market, while software solutions show rapid growth due to AI integration and workflow management needs. Challenges like limited awareness and infrastructure gaps remain, but ongoing investments position Latin America as an emerging digital pathology market.

Explore Extensive ongoing Coverage on Healthcare Sector:

Neurorehabilitation Devices Market - Global Opportunity Analysis and Industry Forecast – 2032 https://www.skyquestt.com/report/neurorehabilitation-devices-market 

Adult Diapers Market - Global Opportunity Analysis and Industry Forecast – 2032 https://www.skyquestt.com/report/adult-diapers-market 

Electronic Skin Market - Global Opportunity Analysis and Industry Forecast – 2032 https://www.skyquestt.com/report/electronic-skin-market 

Cell Cryopreservation Market - Global Opportunity Analysis and Industry Forecast – 2032 https://www.skyquestt.com/report/cell-cryopreservation-market 

Recombinant DNA Technology Market - Global Opportunity Analysis and Industry Forecast – 2032 https://www.skyquestt.com/report/recombinant-dna-technology-market 

About SkyQuest Technology Consulting

SkyQuest Technology Consulting is a leading Strategy Consulting and Market Research firm, provides syndicated as well as customized research reports and growth consulting services, trusted by CXOs from Fortune 500 Companies, Start-ups, and MSMEs. The company comprises a team of expert research analysts and consultants, adding more than 1200 market research reports in our database each year. These reports offer in-depth analysis on 40+ industries & sub industries across 25 major countries worldwide, serving global clients across diverse industries. The company specializes in delivering customized intelligence, data-driven insights, and strategic advisory services that enable businesses to stay competitive and make informed decisions in rapidly evolving industries.

Contact Us:
SkyQuest Technology Consulting
1 Apache Way, Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/

Logo: https://mma.prnewswire.com/media/2446095/SkyQuest_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/digital-pathology-market-to-grow-at-a-cagr-of-7-8-from-2025-to-2032--skyquest-technology-consulting-302542960.html

SOURCE SkyQuest Technology